1. 869PDTumor molecular characteristics in patients (pts) with international metastatic renal cell carcinoma database consortium (IMDC) good (G) and intermediate/poor (I/P) risk. (23rd October 2018) Authors: Beuselinck, B; Verbiest, A; Couchy, G; Job, S; de Reyniès, A; Caruso, S; Verkarre, V; Rioux-Leclercq, N; Schöffski, P; Vano, Y; Elaidi, R-T; Lerut, E; Albersen, M; Oudard, S; Zucman-Rossi, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 870PDEfficacy and safety of axitinib in metastatic papillary renal carcinoma (mPRC): Results of a GETUG multicenter phase II trial (Axipap). (23rd October 2018) Authors: Negrier, S; Rioux-Leclercq, N; Ravaud, A; Gravis, G; Geoffrois, L; Chevreau, C M; Rolland, F; Blanc, E; Segura-Ferlay, C; Perol, D; Gross Goupil, M; Dermeche, S; Flechon, A; Albiges, L; Escudier, B Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (21st February 2019) Authors: Escudier, B; Porta, C; Schmidinger, M; Rioux-Leclercq, N; Bex, A; Khoo, V; Grünwald, V; Gillessen, S; Horwich, A Journal: Annals of oncology Issue: Volume 30:Number 5(2019) Page Start: 706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗